Ethyl 3-(ethylthio)butyrate
Common Name: |
Ethyl 3-(ethylthio)butyrate |
IUPAC Name: |
ethyl 3-ethylsulfanylbutanoate |
Molecular Formula: |
C12H18O |
SMILES: |
CCOC(=O)CC(C)SCC |
Inchi: |
1S/C8H16O2S/c1-4-10-8(9)6-7(3)11-5-2/h7H,4-6H2,1-3H3 |
Inchi Key: |
JMXMTQDOJYBDSL-UHFFFAOYSA-N |
Cas No: |
90201-28-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
178.27 |
Mass (g/mol) |
176.087 |
Molar Refractivity |
56.60 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
4 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
3 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
230.00 to 233.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.055 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.081 |
iLOGP |
2.46 |
XLOGP3 |
2.98 |
WLOGP |
2.81 |
MLOGP |
3.06 |
ESOL Log S |
-2.90 |
ESOL Solubility (mg/ml) |
0.224 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.07 |
Ali Solubility (mg/ml) |
0.15 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.50 |
Silicos-IT Solubility (mg/ml) |
0.06 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.27 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.312 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.156 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |